PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Roche to launch SARS-CoV-2 rapid antigen test

Roche is gearing up to launch an antigen test able to “reliably and quickly” triage people suspected of SARS-CoV-2, with results available in just 15 minutes. The ...
Continue Reading →
News

BMS bags US approval for Onureg

The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb's Onureg (azacitidine) for the continued treatment of adults with acute myeloid leukaemia...
Continue Reading →
News

NICE green light for immunotherapy Bavencio

The National Institute for Health and Care Excellence (NICE) has now published final guidelines endorsing NHS use of Merck and Pfizer's immunotherapy Bavencio (avelu...
Continue Reading →
News

EU OKs paediatric use of Gilead’s Epclusa

The European Commission (EC) has expanded marketing authorisation for Gilead's Epclusa (sofosbuvir/velpatasvir/sofosbuvir) to include the treatment of children with ...
Continue Reading →
News

Stoelzle pursues their path towards establishing sustainably long-term success

Being sustainably successful as an international enterprise for Stoelzle means acting responsibly,improving the working conditions and quality of life of our employe...
Continue Reading →
News

J&J to acquire Momenta for $6.5 billion

Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-me...
Continue Reading →
News

Clinical research cut 87% at peak of pandemic

At the peak of the COVID-19 pandemic, clinical research capacity may have been slashed by up to 87% in England, according to a new study led by UCL academics. The ...
Continue Reading →
News

Novartis’ CML drug hits PhIII targets

Novartis' Phase III ASCEMBL study has met its primary goal showing that asciminib was superior to bosutinib in inducing a major molecular response (MMR) in patients ...
Continue Reading →
News

No increased risk from COVID-19 for healthy pregnant women

Healthy pregnant women are not at higher risk of falling seriously ill from COVID-19 than healthy women not pregnant, suggests a study from King's College London. ...
Continue Reading →
News

AbbVie submits Rinvoq for ankylosing spondylitis

AbbVie has filed for approval of Rinvoq (upadacitinib) in the US to treat adult patients with active ankylosing spondylitis. Ankylosing spondylitis is a chronic, p...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026